MedTrace Logo

Non-interventional Study on Patients With Atrial Fibrillation and Cancer

NCT03909386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1514

Last updated 2023-01-12

No results posted yet for this study

Summary

AF and cancer frequently coexist. Since these patients are usually excluded from randomized trials, information on their management and outcome is scarce. Occurrence of relevant clinical events, such as ischemic and hemorrhagic and all-cause mortality and cardiovascular (CV) mortality occurring in patients treated or not with antithrombotic agents needs to be clarified.

A prospective observational registry collecting information, in a real world setting, on the clinical profile of patients with these clinical conditions and on the use of antithrombotic drugs in patients with AF and cancer could improve our knowledge on the management of these high risk patients.

Conditions

Sponsors & Collaborators

  • Heart Care Foundation

    lead OTHER

Principal Investigators

  • Michele M Gulizia, MD · Heart Care Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-26
Primary Completion
2021-09-30
Completion
2022-09-30

Countries

  • Belgium
  • Ireland
  • Italy
  • Netherlands
  • Portugal
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03909386 on ClinicalTrials.gov